Literature DB >> 18414384

Neuropharmacology of addiction--setting the scene.

A J Lawrence1, P M Beart, P W Kalivas.   

Abstract

Addiction is a complex disorder, affecting not only the individual addict, but also their family and the community at large. While therapeutic strategies are available for the treatment of some forms of substance abuse/dependence, these are not without problems and are not universally efficacious. Moreover, in some instances (for example, cocaine addiction), there are still no medications specifically registered as treatment options. In this themed issue of the British Journal of Pharmacology, we highlight a number of addictions from a pharmacological perspective, with an emphasis on both mechanism and potential therapeutic approaches that are either under development or reflect preclinical work. As such, the authors endeavour to describe the latest thinking on the neural theory of addiction and corresponding novel pharmacotherapeutic targets, and in this way to set the stage for future advances in research and drug development. In addition, we have also attempted to draw attention to the clinicians' perspective in terms of the interface between basic science and care provision.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414384      PMCID: PMC2442453          DOI: 10.1038/bjp.2008.131

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

Review 1.  Drug addictions: towards socially accepted and medically treatable diseases.

Authors:  Philippe Pouletty
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

Review 2.  Addiction and the brain antireward system.

Authors:  George F Koob; Michel Le Moal
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

Review 3.  Addiction: the clinical interface.

Authors:  D Nutt; A Lingford-Hughes
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 4.  Genetic factors influencing alcohol dependence.

Authors:  R D Mayfield; R A Harris; M A Schuckit
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

Review 5.  Drug addiction as a pathology of staged neuroplasticity.

Authors:  Peter W Kalivas; Charles O'Brien
Journal:  Neuropsychopharmacology       Date:  2007-09-05       Impact factor: 7.853

Review 6.  Neuroplasticity in the mesolimbic dopamine system and cocaine addiction.

Authors:  M J Thomas; P W Kalivas; Y Shaham
Journal:  Br J Pharmacol       Date:  2008-03-17       Impact factor: 8.739

Review 7.  From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

Authors:  I S McGregor; P D Callaghan; G E Hunt
Journal:  Br J Pharmacol       Date:  2008-05       Impact factor: 8.739

Review 8.  Neuropharmacology of alcohol addiction.

Authors:  V Vengeliene; A Bilbao; A Molander; R Spanagel
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

Review 9.  Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.

Authors:  Barry J Everitt; Trevor W Robbins
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

  9 in total
  3 in total

1.  Continuity and change.

Authors:  H P Rang; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

2.  Differential peptidomics assessment of strain and age differences in mice in response to acute cocaine administration.

Authors:  Elena V Romanova; Stanislav S Rubakhin; John R Ossyra; Jonathan A Zombeck; Michael R Nosek; Jonathan V Sweedler; Justin S Rhodes
Journal:  J Neurochem       Date:  2015-08-25       Impact factor: 5.372

Review 3.  Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.

Authors:  C E Van Skike; S E Maggio; A R Reynolds; E M Casey; M T Bardo; L P Dwoskin; M A Prendergast; K Nixon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-12       Impact factor: 5.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.